Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Trial Design and Baseline Characteristics from REMODEL: A Mechanistic Study of Semaglutide vs. Placebo in People with Type 2 Diabetes and CKD
PaperCitations, authors & open-access status
Trial Design and Baseline Characteristics from REMODEL: A Mechanistic Study of Semaglutide vs. Placebo in People with Type 2 Diabetes and CKD is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2024 year and closed oa status.
2
Citations
2024
Year
closed
OA Status